Literature DB >> 25766005

Intestinal carriage of Shewanella xiamenensis simulating carriage of OXA-48-producing Enterobacteriaceae.

Alberto Antonelli1, Domenica Maria Di Palo2, Angelo Galano2, Sabrina Becciani3, Carlotta Montagnani3, Patrizia Pecile4, Luisa Galli5, Gian Maria Rossolini6.   

Abstract

Positivity for bla(OXA-48)-like carbapenemase genes was revealed by molecular testing of a surveillance rectal swab from a patient who had previously been colonized and infected by an OXA-48-producing Klebsiella pneumoniae. Positivity was due to a coincidental carriage of Shewanella xiamenensis harboring a new bla(OXA-48)-like gene, while the K. pneumoniae was no longer present.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbapenemase-producing Enterobacteriaceae; Molecular testing; OXA-48 carbapenemase; Shewanella xiamenensis; Surveillance

Mesh：

Substances：

Year:  2015        PMID： 25766005     DOI： 10.1016/j.diagmicrobio.2015.02.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  16 in total

Review 1.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  Chromosome-Based blaOXA-48-Like Variants in Shewanella Species Isolates from Food-Producing Animals, Fish, and the Aquatic Environment.

Authors:  Daniela Ceccarelli; Alieda van Essen-Zandbergen; Kees T Veldman; Nedzib Tafro; Olga Haenen; Dik J Mevius
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436.

Authors:  Agnès B Jousset; Laura Dabos; Rémy A Bonnin; Delphine Girlich; Anaïs Potron; Nicolas Cabanel; Laurent Dortet; Philippe Glaser; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

Review 5.  Current trends of human infections and antibiotic resistance of the genus Shewanella.

Authors:  K Yousfi; S Bekal; V Usongo; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-15       Impact factor: 3.267

6.  Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase.

Authors:  L Dabos; A B Jousset; R A Bonnin; N Fortineau; A Zavala; P Retailleau; B I Iorga; T Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

7.  Complete Genome Sequence of an Extensively Drug-Resistant Shewanella xiamenensis Strain Isolated from Algerian Hospital Effluents.

Authors:  Khadidja Yousfi; Abdelaziz Touati; Sadjia Bekal
Journal:  Genome Announc       Date:  2016-11-10

8.  Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.

Authors:  Tommaso Giani; Alberto Antonelli; Mariasofia Caltagirone; Carola Mauri; Jessica Nicchi; Fabio Arena; Elisabetta Nucleo; Silvia Bracco; Annalisa Pantosti; Francesco Luzzaro; Laura Pagani; Gian Maria Rossolini
Journal:  Euro Surveill       Date:  2017-08-03

9.  Shewanella spp. infections in Gran Canaria, Spain: retrospective analysis of 31 cases and a literature review.

Authors:  Alberto J Martín-Rodríguez; Oriol Martín-Pujol; Fernando Artiles-Campelo; Margarita Bolaños-Rivero; Ute Römling
Journal:  JMM Case Rep       Date:  2017-12-07

10.  First clinical isolation report of Shewanella algae from the stools of a patient with acute enteritis in Spain.

Authors:  E Fernández-Fernández; A J Martín-Rodríguez; M Hernández; J M Navarro-Marí; U Römling; J Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2018-04-02       Impact factor: 1.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.